Erythromycin Stearate 250mg Capsules from Japan
Capsules containing 250mg erythromycin stearate, a macrolide antibiotic in single-ingredient form for skin and soft tissue infections, packaged in measured doses for pharmacy retail. Fits HTS 3004.20.0020 due to erythromycin specificity and retail presentation excluding veterinary uses.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Include stability data and bioequivalence studies for ANDA approval; use child-resistant packaging
• Verify no cross-contamination with beta-lactams
• Declare exact potency to avoid duty disputes